4.6 Article

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures

Journal

PLOS ONE
Volume 12, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0177743

Keywords

-

Funding

  1. Major scientific and technological specialized project of China for 'significant new formulation of new drugs' - National health and family planning commission of the people's republic of china [2013ZX09102057]
  2. Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB)
  3. SHUB

Ask authors/readers for more resources

Computational drug repositioning has been proved as an effective approach to develop new drug uses. However, currently existing strategies strongly rely on drug response gene signatures which scattered in separated or individual experimental data, and resulted in low efficient outputs. So, a fully drug response gene signatures database will be very helpful to these methods. We collected drug response microarray data and annotated related drug and targets information from public databases and scientific literature. By selecting top 500 up-regulated and down-regulated genes as drug signatures, we manually established the DrugSig database. Currently DrugSig contains more than 1300 drugs, 7000 microarray and 800 targets. Moreover, we developed the signature based and target based functions to aid drug repositioning. The constructed database can serve as a resource to quicken computational drug repositioning. Database URL: http://biotechlabiudamedu.cnidatabase/drugsig/.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available